aap Implantate AG (STU:AAQ1) Scaled Net Operating Assets: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AAQ1 aap Implantate AG STU:AAQ1
54 GF Score
Price €1.68
GF Value €1.29
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is aap Implantate AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

aap Implantate AG's operating assets for the quarter that ended in Jun. 2026 was €15.82 Mil. aap Implantate AG's operating liabilities for the quarter that ended in Jun. 2026 was €3.96 Mil. aap Implantate AG's Total Assets for the quarter that ended in Dec. 2025 was € Mil. Therefore, aap Implantate AG's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2026 was N/A.


aap Implantate AG Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for aap Implantate AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aap Implantate AG Scaled Net Operating Assets Chart

aap Implantate AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.68 0.56 0.54 -

aap Implantate AG Semi-Annual Data
Jun14 Dec14 Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.49 0.59 - 0.74

STU:AAQ1 vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, aap Implantate AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Scaled Net Operating Assets falls into.


STU:AAQ1
54GF Score
aap Implantate AG STU:AAQ1
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aap Implantate AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

aap Implantate AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(0-0)/15.837
=0.00

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=0

aap Implantate AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2026 )
=(Operating Assets (Q: Jun. 2026 )-Operating Liabilities (Q: Jun. 2026 ))/Total Assets (Q: Dec. 2025 )
=(15.819-3.955)/
=N/A

where

Operating Assets(Q: Jun. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=16.105 - 0.286
=15.819

Operating Liabilities(Q: Jun. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.926 - 3.275 - 0.696
=3.955

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is aap Implantate AG (STU:AAQ1) Overvalued in 2026?

Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued. The current stock price of €1.68 is trading 30.2% above its estimated GF Value™ of €1.29. GuruFocus considers aap Implantate AG to be Modestly Overvalued.

Key valuation signals for STU:AAQ1:

  • Scaled Net Operating Assets: N/A
  • GF Value™: €1.29 vs. price of €1.68 (30.2% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the STU:AAQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aap Implantate AG Business Description

Other Exchanges 0N5A:UKAAQ1:Germany
Address Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
54GF Score

Get the complete analysis for STU:AAQ1

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.68
Price
€1.29
GF Value